The most common question after a year on a GLP-1 is what happens if you stop. The honest answer is that most of the weight returns, and that this is a property of the disease rather than a failure of the person.
Trial data is fairly consistent: after stopping, a large majority of lost weight is regained over the following year, and the metabolic improvements — blood pressure, lipids, glucose — largely track back with it. Understanding why makes the decision clearer.
Why the weight comes back
Obesity behaves like a chronic condition with a defended set point. The body responds to weight loss by increasing appetite signalling and reducing energy expenditure, and these adaptations persist long after the weight has gone. GLP-1 medications work against that by acting on appetite and satiety pathways directly.
Remove the medication and the underlying physiology is still there, unchanged. Hunger returns, often quite abruptly, and typically feels stronger than it did before treatment because the contrast is sharp.
The useful comparison is blood pressure medication. Nobody expects a normal reading to persist after stopping an antihypertensive, and nobody frames the return of hypertension as a personal failing. The same logic applies here, but the cultural framing around weight makes it harder to see.
Reasons people stop
Cost is the most common by a distance — these medications are expensive and coverage in Canada is inconsistent. Others stop because of side effects, supply problems, pregnancy plans, or because they have reached a goal and assume treatment was a temporary measure.
Those reasons deserve different responses. A cost problem may be addressed by exploring coverage, alternative agents, or a lower maintenance dose. A side effect problem may respond to dose adjustment or switching. Reaching a goal is not, on its own, a clinical reason to stop.
If you are going to stop
Some things genuinely help, even though none of them fully prevent regain.
- Taper rather than stopping abruptly where your prescriber agrees. Appetite returns more gradually and the transition is easier to manage
- Have the habits in place before you stop, not after. Protein intake, resistance training, sleep and meal structure are far easier to maintain than to build while hunger is climbing
- Prioritise resistance training. A meaningful share of weight lost on GLP-1s is lean mass, and preserving muscle protects resting metabolic rate
- Keep monitoring. Weight, blood pressure and glucose. Catching an upward trend at three kilograms is a different conversation from catching it at fifteen
- Stay in contact with your prescriber. Restarting early if regain begins is far more effective than restarting after it has completed
Maintenance dosing
For many people the more realistic plan is not stopping but continuing at the lowest dose that holds the result. This is standard practice in other chronic conditions and it is increasingly how obesity treatment is approached. It may also reduce cost, though not always proportionally.
Whether this suits you depends on your response, your side effects, your other conditions and your coverage. It is worth raising explicitly rather than assuming stopping is the only alternative to a full dose.
The framing that helps
If weight returns after stopping, that is the condition reasserting itself, not evidence that the treatment failed or that you did. The treatment worked — you can see it in the record of what happened while you were on it.
The decision worth making deliberately, with your prescriber, is what the long-term plan looks like: continue, reduce to maintenance, or stop with a structured plan and monitoring. Any of those can be reasonable. Stopping without a plan is the one that reliably disappoints.
